Navigation Links
ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants

e unforeseen safety issues, will have favorable results in future clinical trials or will receive regulatory approval. In addition, future activities around ANA380/LB80380 are currently under discussion between LG Life Sciences and Anadys and there is no guarantee that the parties will be able to agree to a global development plan or next steps for the program. Furthermore, Anadys' results may be affected by risks related to its collaborative relationships with Novartis and LG Life Sciences, competition from other biotechnology and pharmaceutical companies, its effectiveness at managing its financial resources, its ability to successfully develop and market products, the level of effort that its collaborative partners devote to development and commercialization of its product candidates, difficulties or delays in its pre-clinical studies or clinical trials, difficulties or delays in manufacturing its clinical trials materials, the scope and validity of patent protection for its products, regulatory developments involving future products and its ability to obtain additional funding to support its operations. Risk factors that may cause actual results to differ are more fully discussed in Anadys' SEC filings, including Anadys' Form 10-K for the year ended December 31, 2006. All forward-looking statements are qualified in their entirety by this cautionary statement. Anadys is providing this information as of this date and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

CONTACT: Vince Reardon, Sr. Director, Investor Relations, InvestorRelations & Corporate Communications of Anadys Pharmaceuticals, Inc.,+1-858-530-3653, ; or Ki Seok Kim, GeneralManager, Investor Relations of LG Life Sciences, Ltd., +82-2-3773-0619, vreardon@anadyspharma.com




Page: 1 2 3 4 5 6

Related medicine technology :

1. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
2. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
3. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
6. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
7. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
8. Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer Patients Treated with Therapy Based on Ratiometric Dosing
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
Post Your Comments:
(Date:5/22/2015)... NEW YORK and KING OF PRUSSIA, ... Hemophilia Foundation (NHF) has awarded CSL Behring ... longstanding and unwavering commitment to advancing science and improving the ... by Paul Perreault , CEO and Managing Director, CSL ... New York City on May 21. ...
(Date:5/22/2015)... , May 22, 2015 ... Assay Market by Product (Consumables, Instruments, Services), by Test ... (ELISA, Chromatography, Flow Cytometry), by End Users - Global ... Assays Market is expected to reach $736.85 Million by ... CAGR of 10.25%. Browse 71 market ...
(Date:5/22/2015)... , May 22, 2015 Research and ... the addition of the "Latest Regulations on ... report to their offering. This is ... issued a guidance on international multi-center clinical trials ... which has begun to be implemented on March ...
Breaking Medicine Technology:National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
(Date:5/22/2015)... Coco Libre, the Official Coconut Water of Zappos.com ... the 104th running of the race. On Sunday, May 17, ... people in one hour—one person about every 10 seconds. ... to the heart of the Bay Area, so unique, whimsical ... the finish line only made sense,” said Jennifer Goodrum, Coco ...
(Date:5/22/2015)... Medivo, Inc., a leader in lab data analytics, ... in ‘Baby Boomers’ Screened for HCV Following the 2012 CDC ... at Digestive Disease Week, May 16-19, 2015. , The ... members Carol Smyth, MB; Jason Bhan, MD; Tatiana Sorokina, MSc; ... Nancy Reau, MD from the University of Chicago, Chicago, IL. ...
(Date:5/22/2015)... Ticket Down is a reputable source for authentic ... Finals Tickets . All seating for the 2015 NHL ... listing. , For the first time in some time, ... Eastern Conference. One of the original franchises in the National ... over the years, but the excitement level for this season ...
(Date:5/22/2015)... 22, 2015 A new program for ... in the field of Physical Therapy. , James ... the mystery out of physical therapy and discusses how ... motion for a variety of ailments and injuries. ... personalized exercise plan that enhances daily activities such as ...
(Date:5/22/2015)... Javon Bea Mercy Health System : ... the highest quality emergency care services, especially by women ... Javon R. Bea, President and CEO of Mercy Health ... to care for and respond to what is most ... for this award, but are selected if they consistently ...
Breaking Medicine News(10 mins):Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2
... Medical Group has announced the opening of its newest ... total number of CareToday clinics to six.CareToday Anthem is ... Mountain Drive and Gavilan Peak Parkway, 39510 North Daisy ... and physician assistants, the clinics offer after hours and ...
... helps stop the growth of new blood vessels has ... cancer, research from Mayo Clinic indicates. , At the ... Oncology (ASCO), Mayo investigators report that cancer in ... cancer treated with the drug pazopanib either stopped growing, ...
... Guild will present its annual series of School of ... Wednesday, May 18, 19 & 20, 2009 . This ... a.m. and 12:30 p.m. each day, and May 20 at ... overall. Outreach sessions serving an additional 840 students will ...
... Revenues Climb 84%; Free Cash Flow Exceeds ... Technologies(R), Inc. ("Global Med" or the "Company") ... information technology company, today reported profitability and ... for the first quarter ended March 31, ...
... about genetic risks fosters openness, expert says , , FRIDAY, May ... to decide what to share with their children. But when ... study shows that those who choose to reveal the results ... know that two genes are to blame for the majority ...
... figures are returning to normal,following the swine flu outbreak ... from the press, governments and the,World Health Organisation, travellers ... of the globe. , UK ... customers each,year - reports that flights to both Mexico ...
Cached Medicine News:Health News:Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz. 2Health News:Drug that targets vasculature growth attacks aggressive thyroid cancer 2Health News:Drug that targets vasculature growth attacks aggressive thyroid cancer 3Health News:UPMC Health Plan Sponsors 'School of Swing' with MCG Jazz 2Health News:UPMC Health Plan Sponsors 'School of Swing' with MCG Jazz 3Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 2Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 3Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 4Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 5Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 6Health News:Sharing Cancer Info May Be Empowering 2Health News:DialAFlight Announce Bookings Upsurge After Swine Scare 2
...
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium...
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
Medicine Products: